PF-06444752
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06444752, covering 2016-07-11 to 2016-07-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis [Phase 1]